Theralase Technologies Market Cap

Theralase Technologies has a market cap or net worth of $35.09 million as of June 20, 2025. Its market cap has increased by 21.21% in one year.

Market Cap

35.09M

Enterprise Value

35.19M

Revenue

660.29K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.14

Market Cap Chart

Since April 2, 1996, Theralase Technologies's market cap has increased from 6.14M to 35.09M, an increase of 471.34%. That is a compound annual growth rate of 6.14%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	32.99M	-27.70%
Dec 31, 2024	45.64M	50.64%
Dec 28, 2023	30.29M	-40.82%
Dec 30, 2022	51.19M	-15.43%
Dec 31, 2021	60.53M	98.73%
Dec 31, 2020	30.46M	-43.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Elite Pharmaceuticals	827.80M
Veradigm	747.25M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	425.33M
American Oncology Network	408.69M
Northwest Biotherapeutics	390.42M

Market Cap Rankings